Skip to main content

Advertisement

ADVERTISEMENT

poster

Transforming Health and Resiliency through Integration of Values-based Experiences (THRIVE) is a clinical program that was developed at Department of Veterans Affairs for Veterans and sta...
10/26/2023
Discover how TeleHelp Ukraine revolutionizes mental health care amidst the crisis caused by the Russian invasion. This non-profit utilizes telemedicine, offering secure video consultation...
10/26/2023
This analysis presents the opinions of US-practicing psychiatric clinicians on a hypothetical case where a psychiatrist introduces the topic of transitioning to a long-acting injectable a...
10/26/2023
Our hypothesis postulates that those who had employer-based insurance were negatively affected and those who had public insurance were positively affected. Those who were on public insura...
10/26/2023
IDgenetix is the only clinically validated pharmacogenomic test that combines drug-drug interactions (DDI) and lifestyle factors with drug-gene interactions and demonstrates improved outc...
10/26/2023
This large, cross-sectional, observational study will be conducted in a sample reflecting bipolar I disorder prevalence in real-world settings to confirm the performance of the Rapid Mood...
10/26/2023
KINECT™-HD2 is an ongoing, long-term open-label study of once-daily valbenazine for chorea associated with Huntington disease. Pre-planned interim analyses indicate early chorea improveme...
10/26/2023
The results of a survey of 100 psychiatrists and 100 neurologists managing patients with DIMDs suggested a higher use of telehealth among psychiatrists vs neurologists post-COVID. Psychia...
10/26/2023
This meta-analysis of dual orexin receptor antagonists illustrates that the impact of treatment on next-day driving performance varies across treatments within the DORA drug class.
10/26/2023
this is the first Systematic review that discussed the use of the escitalopram in GAD in pediatric patients, regarding use, safety efficacy, and possible treatment prediction methods and ...
10/26/2023

Advertisement